MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds

thought leadership

Innovation in dermatology: The latest pipeline and clinical data analysis from leading clinicians

FIDE | 10/17/2023

Leading clinicians and experts at FIDE, one of Avalere Health’s Expert Partnerships, analyze dermatology pipelines and explore the latest clinical data to uncover how innovative treatments are shaping the future of care in hidradenitis suppurativa, alopecia areata, vitiligo, psoriasis, and atopic dermatitis.

The dermatology landscape is experiencing a paradigm shift in which manufacturers are developing targeted and effective therapies to meet significant unmet needs in a range of therapeutic areas, from psoriasis and atopic dermatitis to hidradenitis suppurativa, alopecia areata, and vitiligo.

This revolution in treatment and care was sparked in 2003 and 2004 by the approval of three biologic agents—alefacept, efalizumab, and etanercept—for the treatment of moderate to severe plaque psoriasis. Since then, major investment across dermatology pipelines has stimulated the development of numerous targeted and highly effective therapies for psoriasis, including, most recently, the approval of the first and only tyrosine kinase 2 (TYK2) inhibitor. A similar therapeutic revolution is currently unfolding in atopic dermatitis, in which monoclonal antibodies, as well as the development of other novel Janus kinase (JAK) inhibitors, have greatly expanded treatment options.

Now, manufacturers are turning their attention to addressing unmet needs in other dermatologic diseases, with recent approvals and multiple Phase 2 and 3 trials underway for several therapies for hidradenitis suppurativa, alopecia areata, and vitiligo.

FIDE, one of Avalere Health’s Expert Partnerships, leverages its expertise in the treatment of chronic inflammatory skin diseases to provide unrivaled clinical insight to the biopharmaceutical industry. The faculty comprises an independent network of internationally renowned clinical investigators and clinicians who provide diverse perspectives on the latest advances in these conditions based on their experience as trialists and working in academia and community-based practices.

We spoke to members of FIDE about the latest developments and insights in hidradenitis suppurativa, alopecia areata, vitiligo, psoriasis, and atopic dermatitis. They draw from their experience at FIDE’s conference analysis programs at the European Academy of Dermatology and Venereology (EADV) 2022 and American Academy of Dermatology (AAD) 2023 congresses. In this article, they highlight the promising new therapies being evaluated in Phase 2 and 3 clinical trials, explore the merits and flaws of the data, and identify some important issues that may influence patient care.

Better health happens when we connect

Contact us to learn how we work in partnership with FIDE to meet unmet needs in dermatology.

Get in touch

Thought leadership

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement


Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.